Varies by study
Conventional glycemic control
Total Trials
3
Max Phase
-
Type
MIXED
Molecule
-
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
0 source entries across 0 studies. This list may not include all unresolved or historical entries.
Success Metrics
Completion Rate
0%(0/2)
Active Trials
0(0%)
Terminated
2(67%)
Phase Distribution
Phase 3
1
33%
Not Applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Terminated(2)
Other(1)
Detailed Status
Terminated2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (33.3%)
N/A2 (66.7%)
Trials by Status
terminated267%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
Clinical Trials (3)
Showing 3 of 3 trials
NCT00353275Not Applicable
Hyperglycemia in Surgical Infections
NCT00487162Not Applicable
The Association Between Peri-Operative Hyperglycemia and Major Morbidity and Mortality
NCT00591071Phase 3
Impact of 2 Blood Glucose Levels on Hospital Mortality in Patients Admitted in ICU
All 3 trials loaded
Drug Details
- Intervention Type
- Varies by study
- Total Trials
- 3